HCP Case Studies
Oral Pressure Therapy (OPT) in Obstructive Sleep Apnea
Download the case study Oral Pressure Therapy (OPT) in Obstructive Sleep Apnea (opens in a new tab)
MRI-based evaluation of OPT demonstrated significant anatomical airway changes in obstructive sleep apnea responders. OPT enlarged the retropalatal airway through anterior displacement of the soft palate, resulting in marked apnea–hypopnea index reduction. These mechanistic findings support OPT as a targeted, anatomy-driven alternative for selected patient's intolerant of CPAP.
From the case study
PPTX
Oral Pressure Therapy (OPT) in Obstructive Sleep Apnea
Successful OSA Symptom Control - iNAP
Mandibular advancement oral appliance therapy provided effective symptom control in a CPAP-intolerant obstructive sleep apnea patient. Clinical evidence shows meaningful reductions in apnea severity, improved daytime symptoms, and high long-term adherence. Despite less AHI reduction than CPAP, superior nightly usage supports oral appliances as a practical alternative for selected OSA patients.
Feb 3, 2026
Single-Night Feasibility Study of Mask-Free Therapy
A single-night feasibility study evaluated mask-free intraoral negative-pressure therapy in obstructive sleep apnea patient's intolerant to CPAP. Results demonstrated significant reductions in apnea–hypopnea index, improved oxygenation, and enhanced sleep continuity. Rapid polysomnography-based assessment enabled early responder identification, supporting oral negative-pressure therapy as a practical, non-invasive alternative for selected patients.
Jan 7, 2026
iNAP Therapy in a Middle-Aged Male with Moderate OSA
A middle-aged man with moderate obstructive sleep apnea demonstrated clinically meaningful improvement following iNAP therapy. After two months of nightly use, apnea–hypopnea index and arousal burden decreased significantly, accompanied by marked improvement in daytime sleepiness. This case highlights iNAP as a potential non-invasive alternative for selected patient's intolerant to CPAP.
Jan 7, 2026